`
` PROTECTIVE ORDER MATERIAL
`
`
`
`28th November, 201 3
`
`2706 consecutively mled patients In 93 octane from 17 cauliflo-
`
`Transfemoral data at one year (N = 1685)
`
`0 85% survival n patients mowing
`tho SAPIEN )(T Transcathatar Hand Valve
`
`- 93% none/traceormildparavalvularleak -0 90% NYHA Class VII
`
`—OEDWARDS lllflscATHETER HEART VALVE PIOGIII‘
`
`THE SOURCE XT POST—APPROVAL
`
`STUDY 8: SUBANALYSES
`
`Edwards Ln'encnencaa would like hothank al parbcqnhng l-ba‘l Tm for
`
`their outstand‘ng dedication to In rigorous SGHOE XT post-mama study.
`
`
`Highly Confidential
`
`PROTECTIVE ORDER MATERIAL
`
`EDWARDS 01807696
`
`Page 42 of 53
`
`
`
`
`
`Highly Confidential
`
`PROTECTIVE ORDER MATERIAL
`
`EDWARDS 01807697
`
`
`
`Leveraiini Evidence —
`
`J Am Coll Cardiol. 2013;62(18_51):8219-3219
`
`Transfemoral transcatheter aortic valve implantation with the edwards sapien versus
`
`the medtronic corevalve device
`
`EM. Wiegerinck et aI. Academical Medical Center, University of Amsterdam,
`
`Amsterdam, Netherlands
`
`
`
`Highly Confidential
`
`PROTECTIVE ORDER MATERIAL
`
`EDWARDS 01807698
`
`Page 44 of 53
`
`
`
`Page 45 of 53
`
` PROTECTIVE ORDER MATERIAL
`
`